{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:41:23Z","timestamp":1783654883476,"version":"3.55.0"},"reference-count":59,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82074430"],"award-info":[{"award-number":["82074430"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81803979"],"award-info":[{"award-number":["81803979"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangdong Basic and Applied Basic Research Foundation, China","award":["2022A1515011674"],"award-info":[{"award-number":["2022A1515011674"]}]},{"name":"Guangdong Basic and Applied Basic Research Foundation, China","award":["2024A1515011722"],"award-info":[{"award-number":["2024A1515011722"]}]},{"name":"Guangdong Basic and Applied Basic Research Foundation, China","award":["2024A1515012176"],"award-info":[{"award-number":["2024A1515012176"]}]},{"name":"Science and Technology Planning Project of Guangzhou, China","award":["2024B03J1261"],"award-info":[{"award-number":["2024B03J1261"]}]},{"name":"Science and Technology Planning Project of Guangzhou, China","award":["2024B03J1262"],"award-info":[{"award-number":["2024B03J1262"]}]},{"name":"Scientific Research Project of Administration of Traditional Chinese Medicine of Guangdong Province of China","award":["20241062"],"award-info":[{"award-number":["20241062"]}]},{"name":"Fourth Batch of TCM Clinical Outstanding Talent Program of China","award":["444258"],"award-info":[{"award-number":["444258"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["21623122"],"award-info":[{"award-number":["21623122"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"name":"undergraduate innovation and entrepreneurship training program of Guangdong Province","award":["S202410559127"],"award-info":[{"award-number":["S202410559127"]}]},{"name":"Guangdong Basic and Applied Basic Research Foundation in 2026, China"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Background: Pyroptosis, a pro-inflammatory programmed cell death process, is a key player in tumor biology, including in triple-negative breast cancer (TNBC). Inhibiting G9a has been proven to exert anticancer effects; however, the molecular mechanism of the effects remains unclear. The study aimed to illustrate whether inhibiting G9a can suppress the process of TNBC cells by promoting pyroptosis and investigate the underlying mechanisms. Methods: MCF-10A, MDA-MB-231 and SUM159PT cell lines were used for in vitro study. CCK8 and EdU staining assay were used to examine the cell proliferation, and flow cytometry assay was performed to evaluate cell death. Inflammatory factors were measured by ELISA kits. The mRNA and protein expression levels were analyzed by qRT-PCR, Western blot, and immunofluorescence staining. Transmission electron microscopy was used to observe the morphological changes in cells. Results: We found that knockdown of G9a suppressed the growth and the abilities of invasion and migration, induced pyroptosis, and increased the expression of RIG-I, p-STAT1, and GSDME of TNBC. Furthermore, a RIG-I inhibition Cyclo (Phe-Pro) partially rescued the activation of pyroptosis enhanced by knockdown of G9a. Conclusions: These findings indicate that inhibiting the function of G9a induces pyroptosis in TNBC cells by the RIG-1\/STAT1\/GSDME pathway, which provides a new therapeutic target for TNBC treatment.<\/jats:p>","DOI":"10.3390\/biom16030345","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:35:17Z","timestamp":1772022917000},"page":"345","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting G9a Exerts Pleiotropic Suppression in Triple-Negative Breast Cancer Cells: Cooperatively Inducing Pyroptosis and Apoptosis"],"prefix":"10.3390","volume":"16","author":[{"given":"Jialin","family":"Li","sequence":"first","affiliation":[{"name":"The First School of Clinical Medicine, State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guijuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Nursing, Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyang","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Jinan University, No. 601, West Huangpu Avenue, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianxin","family":"Yan","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Jinan University, Guangzhou 510632, China"},{"name":"School of Traditional Chinese Medicine, Jinan University, No. 601, West Huangpu Avenue, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ma","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Jinan University, Guangzhou 510632, China"},{"name":"School of Traditional Chinese Medicine, Jinan University, No. 601, West Huangpu Avenue, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","article-title":"Breast cancer","volume":"389","author":"Harbeck","year":"2017","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"123082","DOI":"10.1016\/j.lfs.2024.123082","article-title":"Unveiling the intricate dance: Obesity and tnbc connection examined","volume":"357","author":"Hussein","year":"2024","journal-title":"Life Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1038\/s41467-019-10743-7","article-title":"Death effector domain-containing protein induces vulnerability to cell cycle inhibition in triple-negative breast cancer","volume":"10","author":"Ni","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast cancer treatment: A review","volume":"321","author":"Waks","year":"2019","journal-title":"JAMA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.tranon.2019.04.010","article-title":"Activation of pyroptotic cell death pathways in cancer: An alternative therapeutic approach","volume":"12","author":"Nagarajan","year":"2019","journal-title":"Transl. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.15430\/JCP.2017.22.2.62","article-title":"Inflammasome as a therapeutic target for cancer prevention and treatment","volume":"22","author":"Thi","year":"2017","journal-title":"J. Cancer Prev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature18590","article-title":"Pore-forming activity and structural autoinhibition of the gasdermin family","volume":"535","author":"Ding","year":"2016","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"14128","DOI":"10.1038\/ncomms14128","article-title":"Cleavage of dfna5 by caspase-3 during apoptosis mediates progression to secondary necrotic\/pyroptotic cell death","volume":"8","author":"Rogers","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.7150\/ijbs.60292","article-title":"Cisplatin induces pyroptosis via activation of meg3\/nlrp3\/caspase-1\/gsdmd pathway in triple-negative breast cancer","volume":"17","author":"Yan","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.31557\/APJCP.2024.25.2.447","article-title":"Effect of radiotherapy on activating the pyroptotic cell death pathway in breast cancer patients: The role of serum gsdmd-ct, nlrp3 and il-18","volume":"25","author":"Elwany","year":"2024","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11864-017-0506-9","article-title":"Role of platinum in early-stage triple-negative breast cancer","volume":"18","author":"Khatib","year":"2017","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.7150\/thno.58322","article-title":"Tumor suppressor drd2 facilitates m1 macrophages and restricts nf-kappab signaling to trigger pyroptosis in breast cancer","volume":"11","author":"Tan","year":"2021","journal-title":"Theranostics"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ni, Y., Shi, M., Liu, L., Lin, D., Zeng, H., Ong, C., and Wang, Y. (2024). G9a in cancer: Mechanisms, therapeutic advancements, and clinical implications. Cancers, 16.","DOI":"10.3390\/cancers16122175"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1101\/gad.2027411","article-title":"H3k9 methyltransferase g9a and the related molecule glp","volume":"25","author":"Shinkai","year":"2011","journal-title":"Genes. Dev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41467-017-00350-9","article-title":"G9a regulates breast cancer growth by modulating iron homeostasis through the repression of ferroxidase hephaestin","volume":"8","author":"Wang","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1073\/pnas.1618706114","article-title":"G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis","volume":"114","author":"Casciello","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"108341","DOI":"10.1016\/j.celrep.2020.108341","article-title":"G9a promotes breast cancer recurrence through repression of a pro-inflammatory program","volume":"33","author":"Mabe","year":"2020","journal-title":"Cell Rep."},{"key":"ref_20","first-page":"2239","article-title":"Unc0638, a g9a inhibitor, suppresses epithelial-mesenchymal transition-mediated cellular migration and invasion in triple negative breast cancer","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Huo, Z., Zhang, S., Su, G., Cai, Y., Chen, R., Jiang, M., Yang, D., Zhang, S., Xiong, Y., and Zhang, X. (2025). Immunohistochemical profiling of histone modification biomarkers identifies subtype-specific epigenetic signatures and potential drug targets in breast cancer. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26020770"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1172\/JCI57349","article-title":"G9a interacts with snail and is critical for snail-mediated e-cadherin repression in human breast cancer","volume":"122","author":"Dong","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ni1087","article-title":"The rna helicase rig-i has an essential function in double-stranded rna-induced innate antiviral responses","volume":"5","author":"Yoneyama","year":"2004","journal-title":"Nat. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.4049\/jimmunol.1400582","article-title":"Cytosolic double-stranded rna activates the nlrp3 inflammasome via mavs-induced membrane permeabilization and k+ efflux","volume":"193","author":"Franchi","year":"2014","journal-title":"J. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"110127","DOI":"10.1016\/j.vetmic.2024.110127","article-title":"Glaesserella parasuis serotype 5 induces pyroptosis via the rig-i\/mavs\/nlrp3 pathway in swine tracheal epithelial cells","volume":"294","author":"Li","year":"2024","journal-title":"Vet. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/ni.3704","article-title":"Mitochondria are the powerhouses of immunity","volume":"18","author":"Mills","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13045-022-01381-6","article-title":"Jmjd4-demethylated rig-i prevents hepatic steatosis and carcinogenesis","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1158\/0008-5472.CAN-22-2485","article-title":"The m6a reader ythdf2 promotes bladder cancer progression by suppressing rig-i-mediated immune response","volume":"83","author":"Zhang","year":"2023","journal-title":"Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1038\/s41467-022-34885-3","article-title":"Mutant rig-i enhances cancer-related inflammation through activation of circrig-i signaling","volume":"13","author":"Song","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12253-018-0478-5","article-title":"The overexpression of cd80 and isg15 are associated with the progression and metastasis of breast cancer by a meta-analysis integrating three microarray datasets","volume":"26","author":"Li","year":"2020","journal-title":"Pathol. Oncol. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1158\/0008-5472.CAN-18-0730","article-title":"Therapeutically active rig-i agonist induces immunogenic tumor cell killing in breast cancers","volume":"78","author":"Elion","year":"2018","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cyto.2015.12.008","article-title":"Concerted action of histone methyltransferases g9a and prmt-1 regulates pgc-1alpha-rig-i axis in ifngamma treated glioma cells","volume":"89","author":"Ghildiyal","year":"2017","journal-title":"Cytokine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.mad.2016.04.007","article-title":"A brewing understanding of the regulation of bax function by bcl-xl and bcl-2","volume":"161","author":"Renault","year":"2017","journal-title":"Mech. Ageing Dev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13045-023-01405-9","article-title":"Exploiting rig-i-like receptor pathway for cancer immunotherapy","volume":"16","author":"Jiang","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s13238-017-0431-5","article-title":"Rig-i: A multifunctional protein beyond a pattern recognition receptor","volume":"9","author":"Xu","year":"2018","journal-title":"Protein Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"113195","DOI":"10.1016\/j.intimp.2024.113195","article-title":"The rig-i-like receptor signaling pathway triggered by staphylococcus aureus promotes breast cancer metastasis","volume":"142","author":"Zhao","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41420-022-00894-w","article-title":"Myoglobin promotes macrophage polarization to m1 type and pyroptosis via the rig-i\/caspase1\/gsdmd signaling pathway in cs-aki","volume":"8","author":"Li","year":"2022","journal-title":"Cell Death Discov."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Vagia, E., Mahalingam, D., and Cristofanilli, M. (2020). The landscape of targeted therapies in tnbc. Cancers, 12.","DOI":"10.3390\/cancers12040916"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"115095","DOI":"10.1016\/j.jep.2022.115095","article-title":"Cinobufagin induces foxo1-regulated apoptosis, proliferation, migration, and invasion by inhibiting g9a in non-small-cell lung cancer a549 cells","volume":"291","author":"Zhang","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/s41388-020-01591-7","article-title":"G9a controls pluripotent-like identity and tumor-initiating function in human colorectal cancer","volume":"40","author":"Bergin","year":"2021","journal-title":"Oncogene"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"14036","DOI":"10.1096\/fj.201900233RR","article-title":"G9a promotes cell proliferation and suppresses autophagy in gastric cancer by directly activating mtor","volume":"33","author":"Yin","year":"2019","journal-title":"FASEB J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.18632\/oncotarget.3159","article-title":"G9a is essential for emt-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.molcel.2007.01.017","article-title":"Reversal of h3k9me2 by a small-molecule inhibitor for the g9a histone methyltransferase","volume":"25","author":"Kubicek","year":"2007","journal-title":"Mol. Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41420-023-01370-9","article-title":"Targeting pyroptosis in breast cancer: Biological functions and therapeutic potentials on it","volume":"9","author":"Chen","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12079-020-00564-5","article-title":"Gasdermin family: A promising therapeutic target for cancers and inflammation-driven diseases","volume":"14","author":"Wu","year":"2020","journal-title":"J. Cell Commun. Signal."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/s41467-019-09397-2","article-title":"Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation","volume":"10","author":"Rogers","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbrc.2008.03.026","article-title":"Methylation of the dfna5 increases risk of lymph node metastasis in human breast cancer","volume":"370","author":"Kim","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"109434","DOI":"10.1016\/j.cbi.2021.109434","article-title":"Dihydroartemisinin induces pyroptosis by promoting the aim2\/caspase-3\/dfna5 axis in breast cancer cells","volume":"340","author":"Li","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Wang, W., Lopez McDonald, M.C., Kim, C., Ma, M., Pan, Z.T., Kaufmann, C., and Frank, D.A. (2023). The complementary roles of stat3 and stat1 in cancer biology: Insights into tumor pathogenesis and therapeutic strategies. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1265818"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13058-017-0892-8","article-title":"Pathobiology of the 129:Stat1 (\u2212\/\u2212) mouse model of human age-related er-positive breast cancer with an immune infiltrate-excluded phenotype","volume":"19","author":"Mori","year":"2017","journal-title":"Breast Cancer Res."},{"key":"ref_51","first-page":"3065","article-title":"Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer","volume":"8","author":"Widschwendter","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1186\/bcr2753","article-title":"A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer","volume":"12","author":"Yau","year":"2010","journal-title":"Breast Cancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"R16","DOI":"10.1186\/bcr3100","article-title":"Stat1-deficient mice spontaneously develop estrogen receptor alpha-positive luminal mammary carcinomas","volume":"14","author":"Chan","year":"2012","journal-title":"Breast Cancer Res."},{"key":"ref_54","first-page":"34","article-title":"Ifn-gamma facilitates corneal epithelial cell pyroptosis through the jak2\/stat1 pathway in dry eye","volume":"64","author":"Yang","year":"2023","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.ymthe.2023.02.023","article-title":"Ctla-4 blockade induces tumor pyroptosis via cd8(+) t cells in head and neck squamous cell carcinoma","volume":"31","author":"Wang","year":"2023","journal-title":"Mol. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e894","DOI":"10.1002\/ctm2.894","article-title":"Tlr4 aggravates microglial pyroptosis by promoting ddx3x-mediated nlrp3 inflammasome activation via jak2\/stat1 pathway after spinal cord injury","volume":"12","author":"Wang","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ccr.2013.11.011","article-title":"Hepatic rig-i predicts survival and interferon-alpha therapeutic response in hepatocellular carcinoma","volume":"25","author":"Hou","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1002\/cam4.2501","article-title":"Rig-i promotes ifn\/jak2 expression and the endoplasmic reticulum stress response to inhibit chemoradiation resistance in nasopharyngeal carcinoma","volume":"8","author":"Jing","year":"2019","journal-title":"Cancer Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/gutjnl-2024-332281","article-title":"Pharmacological activation of stat1-gsdme pyroptotic circuitry reinforces epigenetic immunotherapy for hepatocellular carcinoma","volume":"74","author":"Tu","year":"2025","journal-title":"Gut"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/3\/345\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:21:56Z","timestamp":1772169716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/3\/345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":59,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["biom16030345"],"URL":"https:\/\/doi.org\/10.3390\/biom16030345","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]}}}